Nonimmunogenetic Viral Capsid Carrier with Cancer Targeting Activity

Although protein nanoparticles (PNPs) (e.g., viral capsids) capable of delivering a broad range of drug agents have shown distinctive advantages over synthetic nanomaterials, PNPs have an intrinsic drawback that hampers their clinical application, that is, potential immunogenicity. Here, a novel met...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Bo‐Ram, Jo, Eunji, Yoon, Hong Yeol, Yoon, Chul Joo, Lee, Hyo‐Jung, Kwon, Koo Chul, Kim, Tae Woo, Lee, Jeewon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Full Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097151/
https://www.ncbi.nlm.nih.gov/pubmed/30128257
http://dx.doi.org/10.1002/advs.201800494

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097151/
https://www.ncbi.nlm.nih.gov/pubmed/30128257
http://dx.doi.org/10.1002/advs.201800494

Ejemplares similares